The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Widespread technical glitches in the MCA-21 V3 portal continue to block smooth annual filings despite deadline extensions. The key takeaway is that systemic issues are impeding statutory compliance ...